全文获取类型
收费全文 | 588848篇 |
免费 | 43532篇 |
国内免费 | 17780篇 |
专业分类
耳鼻咽喉 | 6972篇 |
儿科学 | 10282篇 |
妇产科学 | 12803篇 |
基础医学 | 77991篇 |
口腔科学 | 15161篇 |
临床医学 | 59994篇 |
内科学 | 109487篇 |
皮肤病学 | 10519篇 |
神经病学 | 38957篇 |
特种医学 | 21766篇 |
外国民族医学 | 220篇 |
外科学 | 81034篇 |
综合类 | 44342篇 |
现状与发展 | 56篇 |
一般理论 | 83篇 |
预防医学 | 30118篇 |
眼科学 | 15862篇 |
药学 | 52839篇 |
195篇 | |
中国医学 | 14414篇 |
肿瘤学 | 47065篇 |
出版年
2023年 | 4177篇 |
2022年 | 10303篇 |
2021年 | 13963篇 |
2020年 | 10130篇 |
2019年 | 10085篇 |
2018年 | 12254篇 |
2017年 | 10250篇 |
2016年 | 9926篇 |
2015年 | 13990篇 |
2014年 | 17862篇 |
2013年 | 17722篇 |
2012年 | 25555篇 |
2011年 | 27637篇 |
2010年 | 16396篇 |
2009年 | 13769篇 |
2008年 | 20179篇 |
2007年 | 20863篇 |
2006年 | 21025篇 |
2005年 | 20263篇 |
2004年 | 15524篇 |
2003年 | 14896篇 |
2002年 | 13505篇 |
2001年 | 32284篇 |
2000年 | 33318篇 |
1999年 | 28699篇 |
1998年 | 8421篇 |
1997年 | 7581篇 |
1996年 | 6548篇 |
1995年 | 6021篇 |
1994年 | 5183篇 |
1993年 | 4160篇 |
1992年 | 17622篇 |
1991年 | 16150篇 |
1990年 | 15218篇 |
1989年 | 14821篇 |
1988年 | 13383篇 |
1987年 | 12754篇 |
1986年 | 11664篇 |
1985年 | 10747篇 |
1984年 | 7166篇 |
1983年 | 5776篇 |
1982年 | 2819篇 |
1979年 | 5580篇 |
1978年 | 3385篇 |
1977年 | 3019篇 |
1975年 | 2689篇 |
1974年 | 3105篇 |
1973年 | 2905篇 |
1972年 | 2860篇 |
1971年 | 2796篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
N. V. Bashmakova G. N. Chistiakova I. A. Gazieva Y. M. Trapeznikova D. O. Mazurov 《Gynecological endocrinology》2015,31(10):31-33
AbstractThis study was undertaken to compare the concentrations of pro- and anti-angiogenic growth factors, nitric oxide (NO) stable metabolites in maternal serum and embryonic left ventricular (LV) isovolumic relaxation time (IRT, ms) during the first trimester in two groups of women: with pregnancy conceived by assisted reproductive technologies (ART, n?=?39) and normally conceived (control group, n?=?68) pregnancy. The concentration of vasoconstrictor endothelin 1 was 45.5 times more in ART than in control group. On the contrary, the concentrations of NO stable metabolites in ART were 1.9 times less than in control women. The assessment of angiogenic suppressors in ART women demonstrates the decrease in s-endoglin concentration was 1.6 times and in soluble receptor to vascular endothelial growth factor concentration was 2.0 times in comparison with control group. There was a significant increase in LV IRT in ART embryos in comparison to control ones. These data suggest significant changes in pro- anti-angiogenic factors balance and increase in vascular impedance in ART-conceived embryos. 相似文献
62.
63.
This paper reviews the published literature on a group of developmental disorders of the retina and retinal pigment epithelium which result in focal abnormalities in one or both eyes. They are often asymptomatic, found on routine examination and are generally non-progressive. Some are associated with other systemic abnormalities.Subject terms: Retinal diseases, Eye abnormalities 相似文献
64.
Umar Nadia K. Badshah Maaz B. Sandrasegaran Kumar Ghabril Marwan Agarwal Saurabh Tann Mark Lacerda Marco Kwo Paul Y. 《Digestive diseases and sciences》2015,60(7):2196-2200
Digestive Diseases and Sciences - To determine whether the presence of portal vein thrombosis (PVT) where venous flow within the liver may be altered may delay the diagnosis of HCC and be... 相似文献
65.
Irmak Karaca Suzan Güven Yılmaz Melis Palamar Halil Ateş 《Ocular immunology and inflammation》2020,28(6):947-951
ABSTRACT
Purpose
To investigate the effect of 1% tropicamide on anterior chamber aqueous flare (ACAF) measurements acquired with laser flare meter in patients with pseudoexfoliation. 相似文献66.
67.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
68.
BackgroundArtificial insemination with the husband’s semen (AIH) is an economical and noninvasive method of infertility treatment. However, AIH’s pregnancy rate is much lower than in vitro fertilization (IVF) as its multiple and complex uncertainty factors. Semen quality has been one of the main factors which affect the pregnancy outcome of AIH.MethodsThe relevant parameters of 1,142 AIH cycles were retrospectively studied, including the general parameters and the semen quality parameters among clinical pregnancy, biochemical pregnancy, non-pregnancy group, age, infertility duration, infertility type, body mass index (BMI), cycle count, morphology in previously semen examination, and semen quality parameters on the day of AIH.ResultsThe statistically significant difference was only found on processed total non-forward and non-motile sperm count (N-TFMSC). The mean processed N-TFMSC in the biochemical pregnancy group was 6.37±4.27 million, significantly higher than the other two groups (vs. 4.40±3.15 million or vs. 4.48±3.60 million, P<0.05). The study was then divided into two groups according to processed N-TFMSC, Group 1 ≤5.0 million, and Group 2 >5.0 million. A statistical increase in biochemical pregnancy rate was observed when the processed N-TFMSC was >5.0 million (2.72% vs. 0.90%).ConclusionsProcessed N-TFMSC may be one of the independent factors on AIH’s outcome; it should be given equal attention the same as processed total forward motile sperm count (TFMSC). 相似文献
69.
70.
Wen Wang Yanmei Liu Chuan Yu Jing Tan Weiyi Xiong Duo Dong 《Expert opinion on drug safety》2020,19(3):339-347
ABSTRACTObjectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding.Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with cefoperazone-tazobactam or ceftazidime. Propensity-score matching was used to explore whether treatment with cefoperazone-sulbactam increased the risk of prothrombin time (PT) prolongation, coagulation disorders, and bleeding, or decreased platelets (PLT).Results: The cohort included 23,242 patients. Among patients receiving cefoperazone-sulbactam, the risk of PT prolongation, coagulation disorders, decreased PLT, and bleeding was 5.3%, 9.2%, 15.7%, and 4.2%, respectively. Propensity-score matching analyses suggested that cefoperazone-sulbactam increased the risk of PT prolongation (aOR 2.26, 95% CI 1.61–3.18), coagulation disorders (aOR 1.81, 95% CI 1.43–2.30), and decreased PLT (aOR 1.46, 95% CI 1.25–1.72), but not increase bleeding (aOR 1.05, 95% CI 0.79–1.40) compared with ceftazidime. Patients receiving cefoperazone-sulbactam had higher risk of PT prolongation (aOR 1.53, 95% CI 1.11–2.10), coagulation disorders (aOR 1.53, 95% CI 1.21–1.95), but not decreased PLT (aOR 0.93, 95% CI 0.81–1.07) or bleeding (aOR 1.11, 95% CI 0.87–1.42), compared with those receiving cefoperazone-tazobactam.Conclusion: Cefoperazone-sulbactam may be associated with a higher risk of PT prolongation and coagulation disorders compared with cefoperazone-tazobactam and ceftazidime. 相似文献